Advertise
/
Home/Clinical Tools/LDL Calculator
ACC / AHA 2024 Multi-Society Standard

LDL Cholesterol Clinical Calculator

Computes low-density lipoprotein (LDL-C) using the validated Friedewald and Martin-Hopkins equations, with Non-HDL cholesterol, atherogenic ratios, and statin target classification.

Interactive LDL Cholesterol Calculator

Friedewald & Martin-Hopkins Equations
Select Lab Units
mg/dL
Desirable: < 200 mg/dL
mg/dL
Optimal: ≥ 50 mg/dL
mg/dL
Normal: < 150 mg/dL
Calculated LDL Cholesterol (Friedewald)
130mg/dL(3.4 mmol/L)
Martin-Hopkins Adjusted: 129 mg/dL (3.3 mmol/L)
Borderline High
130–159 mg/dL
< 70 (Optimal)100–129 (Desirable)160–189 (High)190+ (Severe)
Atherogenic Lipoprotein Fractions & Risk Ratios
Non-HDL Cholesterol
160 mg/dL
Target: < 130 mg/dL
VLDL Cholesterol
30 mg/dL
Normal: < 30 mg/dL
Total / HDL Ratio
4.2
Optimal: < 3.5
TG / HDL Ratio
3
Insulin Resistance Marker
ACC / AHA 2024 Practice Guidance

Moderate elevation. Review 10-year ASCVD risk score and risk enhancers (family history, coronary artery calcium score).

ACC / AHA 2024 Statin Target & LDL Risk Classification

LDL-C (mg/dL)LDL-C (mmol/L)Risk TierClinical Statin Strategy
< 70 mg/dL< 1.8 mmol/LTarget for Very High RiskGoal for established secondary prevention (post-MI, stroke) and multiple major ASCVD events.
< 100 mg/dL< 2.6 mmol/LOptimal / High Risk GoalPrimary prevention target for patients with diabetes mellitus or 10-year ASCVD risk ≥ 7.5%.
100 – 129 mg/dL2.6 – 3.3 mmol/LNear Optimal / DesirableTherapeutic lifestyle changes (diet, exercise). Re-evaluate lipid panel in 12 months.
130 – 159 mg/dL3.4 – 4.1 mmol/LBorderline HighInitiate lifestyle therapy; consider moderate-intensity statin if risk enhancers present (CAC > 0).
160 – 189 mg/dL4.1 – 4.9 mmol/LHigh ElevationModerate to high-intensity statin recommended. Target ≥ 50% LDL reduction.
≥ 190 mg/dL≥ 4.9 mmol/LSevere HypercholesterolemiaAutomatic high-intensity statin (Atorvastatin 80mg / Rosuvastatin 40mg). Screen for Familial Hypercholesterolemia.

Formula Comparison: Friedewald vs. Martin-Hopkins

Friedewald (mg/dL): LDL-C = Total Chol - HDL-C - (Triglycerides / 5)
Friedewald (mmol/L): LDL-C = Total Chol - HDL-C - (Triglycerides / 2.2)
Martin-Hopkins: LDL-C = Total Chol - HDL-C - (Triglycerides / Adjustable Factor)
Non-HDL Cholesterol: Non-HDL = Total Chol - HDL-C

The 400 mg/dL Limit: The classic Friedewald formula assumes a constant 5:1 ratio of triglycerides to VLDL cholesterol. When serum triglycerides reach or exceed 400 mg/dL (4.52 mmol/L), chylomicrons accumulate, rendering the fixed ratio invalid and underestimating LDL-C. In such cases, an automated direct enzymatic LDL assay is clinically mandated.

Martin-Hopkins Enhancement: For patients with lower LDL levels (< 70 mg/dL) or elevated triglycerides (150–400 mg/dL), the Martin-Hopkins equation utilizes a personalized divisor ranging from 3.1 to 11.9, avoiding premature undertreatment.

Fasting Standardization

While non-fasting lipid testing is acceptable for initial screening, the Friedewald calculated LDL is most reliable following a 9 to 12-hour overnight fast. Recent high-fat meals elevate triglyceride levels, spuriously suppressing calculated LDL.

CDC / NHLBI Lipid Standardization Program